Navigation Links
Drop of Flu Vaccine Under Tongue Bars Infection
Date:1/28/2008

Mouse study shows promise for human protection in future

MONDAY, Jan. 28 (HealthDay News) -- A drop of vaccine placed under the tongue might one day ward off the flu.

Not only would the new method, so far tested only in mice, be more convenient, it also appears to be more effective than the flu shot or nasal spray, the South Korean researchers noted.

"This has the potential to be widely accepted by people who are afraid of needles, but it's clearly an introductory study and needs to be further studied in humans," said Dr. William Reisacher, an assistant professor of otolaryngology at Weill Cornell Medical College in New York City.

And in developing countries, there is another advantage: indirect prevention of other diseases.

"Sublingual [under the tongue] vaccination elicits broad spectrums of systemic and mucosal immunity. This route is needle-free so that developing countries' people would most benefit to avoid contamination/infection by reused needles," said study senior author Mi-Na Kweon, chief of the Mucosal Immunology Section at the International Vaccine Institute in Seoul.

And according to Kweon, whose study was in this week's issue of the Proceedings of the National Academy of Sciences, "several clinical trials using sublingual route are now ongoing so that it might be not so far away for humans."

Most flu vaccines are delivered via injection, though recently a nasal spray (FluMist) has become available. The flu shot, which contains killed virus, is approved for use in people older than 6 months. The nasal spray is made with live but weakened flu viruses, and is approved for healthy people aged 2 to 49 who are not pregnant.

According to background information in the study, most environmental pathogens, such as the flu virus, enter the body through the respiratory, gastrointestinal and genital tracts.

The sublingual vaccine would provide protection at the point of entry, so to speak. And unlike other oral vaccines, it would avoid subjecting the vaccine to enzymes and acids in the stomach.

Sublingual therapy is already used for allergy drugs in children, primarily in Europe.

In this study, mice were given two doses of either live or inactivated flu virus two weeks apart. Both delivery methods were effective in stimulating the immune system.

When later exposed to a severe form of influenza virus, the animals were fully protected.

Delivering vaccine under the tongue also prevented viruses from traveling to the central nervous system, which is a rare but dangerous complication of the nasal spray.

"They basically showed that the vaccine was able to affect change in the immune system and protected against the flu," Reisacher said. "It's an effective way of exposing a vaccine to the immune system. With sublingual delivery, the vaccine is not absorbed that rapidly but it is maintained in the lining of the mouth -- the mucosa -- allowing the antigen to be exposed [to the immune system]."

More information

For more on current flu vaccines, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: William Reisacher, M.D., assistant professor, otolaryngology, Weill Cornell Medical College, and director, allergy, New York Presbyterian Hospital, New York City; Mi-Na Kweon, Ph.D., chief, Mucosal Immunology Section, International Vaccine Institute, Seoul, Korea; Jan. 28-Feb. 1, 2008, Proceedings of the National Academy of Sciences


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drop of Flu Vaccine Under Tongue Bars Infection
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: